Volume 25, Number 3—March 2019
CME ACTIVITY - Synopsis
Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015
Table 2
Patient | Type of complication | Time from BCG instillation into bladder to diagnosis | Site of culture specimen | Duration of treatment | Outcome |
---|---|---|---|---|---|
1 | Asymptomatic | <6 mo | Urine | Not treated | Alive |
2 | Cystitis | <1 mo | Urine | Not treated | Alive |
3 | Cystitis | 4 mo | Urine | 3 weeks | Alive |
4 | Epididymo-orchitis | ND | Abscess | 9 mo | Alive |
5 | Disseminated | ND | Urine | 2 wks | Died |
6 | Left hip involvement | ND | Abscess | 1 mo | Died |
7 | Parotiditis (case report C) | ND | Abscess | 4 mo | Died |
8 | Prosthetic joint infection (case report B) | 9 mo | Synovial fluid | ND | Alive |
9 | Prosthetic joint infection (case report D) | 4 y | Abscess | 9 mo | Alive |
10 | Septicemia | 1 y | Blood | ND | ND |
11 | Septicemia, military (case report A) | <1 mo | Blood | 9 mo | Alive |
12 | Spondylodiscitis | ND | Abscess | 1 mo | Died |
Spondylodiscitis | 10 y | Abscess | 1 mo | Died |
*BCG, Bacillus Calmette-Guérin; ND, not documented in the medical and public health records that were available during the case reviews.
Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.